On April 29, 2024, Pfizer Inc announced that it held its annual general meeting of shareholders on April 25, 2024, and declared voting results. Accordingly, a shareholder proposal from National Center for Public Policy Research, to Publish a Report on Corporate Contributions was not approved by the shareholders of the Company votes for approval 137,986,751; votes against 3,505,075,475; abstentions 59,125,487; broker non-votes 893,428,132.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
28.82 USD | -2.45% | +2.36% | +0.26% |
Jun. 05 | Relay Therapeutics to Collaborate with Pfizer to Evaluate Breast Cancer Treatment | DJ |
Jun. 05 | Relay Therapeutics to Collaborate With Pfizer to Evaluate Metastatic Breast Cancer Treatment | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.26% | 167B | |
+43.36% | 749B | |
+39.42% | 605B | |
-6.57% | 351B | |
+19.03% | 328B | |
+8.01% | 292B | |
+11.92% | 216B | |
-2.62% | 214B | |
+6.35% | 165B | |
+1.39% | 123B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Declaration of Voting Results by Pfizer Inc